Navigation Links
Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com
Date:10/8/2008

BOSTON, Oct. 8 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company has posted its six-month financials on Pinksheets.com for the period ending June 30, 2008. Revenues generated through the first six-months of 2008 amounted to $204,103, compared with $151,347.53 for the comparable period in 2007. The Company saw an increase in its total cash on hand to $13,242 compared with just over $8,000 at the end of fiscal year 2007.

Solos Endoscopy, Inc. was featured in "High Growth Forecasted for the World Endoscopy Systems Market," a reported that was released on September 4, 2008 in the Reportliner.com catalog. Solos was identified extensively in the report, which analyzes the multibillion dollar worldwide market for endoscopic systems. The Company's total asset base sits just below $4,000,000 as stated in the recently released financial report.

"Solos Endoscopy has had a great first half of this year and our financials reflect that. We believe that the recent development of the Mammo View (TM) product line will greatly improve our goals of profitability and will have highly positive effect on the Company's financials within the coming New Year," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: http://www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Averting postsurgical infections in kids: Give antibiotics within hour before first incision
2. FinCor Holdings Posts Strong Fourth Quarter and Year-End Results
3. TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
4. Irell & Manella Posts Strong Year for Corporate Transactions
5. FinCor Holdings Posts Double-Digit Increases in Revenue and Net Income for Third Quarter
6. Medifast Announces Opening of First Franchise Clinic
7. Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
8. Candice Lane MD Launches Hormone Health MD Plus: The First Doctor Bioidentical Hormone Blog
9. Dr. Gail Golab, Head of AVMA Animal Welfare Division, Becomes First U.S. Veterinarian Credentialed in Animal Welfare
10. Argentyn 23(R) Homeopathic First Aid Gel - Another Worlds First by Natural-Immunogenics Corp. for Healthcare Professionals
11. Researchers create first model for retina receptors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... WASHINGTON D.C. (PRWEB) , ... July 25, 2017 ... ... therapists and their clients, today announced it will be exhibiting and providing demos ... Convention at the Walter E. Washington Convention Center in Washington D.C. from August ...
(Date:7/25/2017)... ... July 25, 2017 , ... USHEALTH Group, Inc. has ... prestigious CEO World Awards®. The coveted annual CEO World Awards program encompasses the ... studies, corporate social responsibility, and milestones from every major industry in the world. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... SignatureCare ... scholarship will be awarded for the fall semester to a deserving student. Get ... Centers Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing student ...
(Date:7/24/2017)... Peru (PRWEB) , ... July 24, 2017 , ... ... for $1,000 total in scholarship awards to be awarded annually to and divided ... demonstrate an interest in bringing awareness to Amazonian plant medicine. To apply for ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... two organizations that already work hand-in-hand on an Innovation Collaboration program, have signed ... access, quality, experience and cost of the care members and patients receive. The ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
(Date:7/10/2017)...  The tenth annual BioPharm America™ will ... at the Sheraton Boston Hotel, September 26–27. The event ... decision makers and innovative biotech startup companies. The event ... two impactful days. BioPharm America is now part of ... opportunities with 4,500+ life science industry influencers participating in ...
Breaking Medicine Technology: